1.14
1.79%
+0.02
Finanzdaten der Co-Diagnostics Inc-Aktie (CODX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
44.69%
3.5552
|
2.4571 | 0.1978 | 0.602 | 1.4015 |
Cost Of Revenue |
1,060%
2.9678
|
0.2558 | 0.4591 | 0.5022 | 0.5158 |
Gross Profit |
73.32%
0.5873
|
2.2013 | -0.2613 | 0.0997 | 0.8857 |
Operating Expenses
|
11.45%
12.41
|
11.14 | 11.73 | 10.05 | 27.01 |
Benefits Costs and Expenses |
36.43%
14.40
|
10.55 | 11.35 | 8.6172 | 26.45 |
Costs And Expenses |
36.43%
14.40
|
10.55 | 11.35 | 8.6172 | 26.45 |
Depreciation and Amortization |
5.58%
0.3129
|
0.2963 | 0.3052 | 0.316 | 0.2986 |
Operating Income/Loss |
32.33%
-11.83
|
-8.936 | -11.99 | -9.9507 | -26.12 |
Nonoperating Income/Loss |
16.97%
0.9828
|
0.8402 | 0.8373 | 1.9354 | 1.0769 |
Income/Loss From Continuing Operations Before Tax |
33.93%
-10.84
|
-8.0958 | -11.16 | -8.0152 | -25.04 |
Income Tax Expense/Benefit, Deferred |
289.04%
4.272
|
-2.2598 | -2.2155 | -2.2147 | -1.3792 |
Income Tax Expense/Benefit |
281.40%
3.834
|
-2.1136 | -2.2383 | -2.2598 | -3.1389 |
Income/Loss From Continuing Operations After Tax |
145.34%
-14.68
|
-5.9822 | -8.9188 | -5.7554 | -21.91 |
Net Income/Loss
|
145.34%
-14.68
|
-5.9822 | -8.9188 | -5.7554 | -21.91 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.86%
0.04
|
29.36 | 29.09 | 29.48 | -0.6302 |
Diluted Average Shares |
99.86%
0.04
|
29.36 | 29.09 | 29.48 | -1.5235 |
Basic Earnings Per Share |
150.00%
-0.50
|
-0.20 | -0.31 | -0.20 | -0.69 |
Diluted Earnings Per Share |
150.00%
-0.50
|
-0.20 | -0.31 | -0.20 | -0.68 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):